Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „Jakavi“
Suchtreffer
Begriffe & Kennungen
Jakavi · 4.8 · In the randomised, placebo-controlled study COMFORT-I 60.6% of Jakavi-treated MF patients and 37.7% of placebo
Eintrag öffnenJakavi · 4.8 · Infections In the phase 3 acute GvHD study (REACH2), during the comparative period, urinary tract infections w
Eintrag öffnenJakavi · 4.8 · Infections In the phase 3 pivotal studies in MF, grade 3 or 4 urinary tract infection was reported in 1.0% of
Eintrag öffnenJakavi · 4.8 · Myelofibrosis The most frequently reported adverse drug reactions were thrombocytopenia and anaemia.
Eintrag öffnenJakavi · 4.8 · Neutropenia In the phase 3 clinical studies in MF, in patients who developed grade 3 or 4 neutropenia, the med
Eintrag öffnenJakavi · 4.8 · Paediatric patients
Eintrag öffnenJakavi · 4.8 · Paediatric patients A total of 106 patients aged 2 to <18 years with GvHD were analysed for safety: 51 patient
Eintrag öffnenJakavi · 4.8 · Polycythaemia vera The most frequently reported adverse drug reactions were anaemia and increased alanine amin
Eintrag öffnenJakavi · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenJakavi · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenJakavi · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenJakavi · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenJakavi · 4.8 · Special populations
Eintrag öffnenJakavi · 4.8 · Summary of the safety profile
Eintrag öffnenJakavi · 4.8 · Summary of the safety profile
Eintrag öffnenJakavi · 4.8 · Table 5 Frequency category of adverse drug reactions reported in clinical studies in GvHD
Eintrag öffnenJakavi · 4.8 · Table 6 Frequency category of adverse drug reactions reported in the phase 3 studies in MF and PV
Eintrag öffnenJakavi · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenJakavi · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenJakavi · 4.8 · The most frequent non-haematological adverse drug reactions in REACH2 (adult and adolescent patients) and in t
Eintrag öffnen